ArticleEuropean child & adolescent psychiatry2026
Psychiatric and substance use disorder polygenic scores are associated with the exposome in youth.
Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Gene-environment correlations (rGE) present challenges for accurately estimating the individual and joint contributions of genetic and environmental influences on risk for psychiatric and substance use disorders. The present study examined rGE between polygenic risk scores (PGS) for psychiatric and substance use disorders and environmental exposures (i.e., exposome factors) using multi-level data spanning youth- and parent-reports, as well as objective measures of the built environment. Participants included 4,797 genetically similar to European reference populations, 1,585 genetically similar to African reference populations, and 2,012 genetically similar to Admixed American reference populations from the Adolescent Brain and Cognitive Development (ABCD) Study. The ABCD study was conducted at 21 sites across the U.S and used a stratified probability sampling design to ensure the cohort recruited was demographically diverse. Based on factor-analytic work conducted by Moore et al. (2022) in the ABCD study, the exposome included 6 factors: household adversity, neighborhood adversity, positive day-to-day experiences, state conservatism/ruralness, family values, and pregnancy/birth complications. Disorder-specific PGS for psychiatric (e.g., major depressive disorder, attention deficit hyperactivity disorder) and substance use conditions (e.g., alcohol use disorders, cannabis use disorders), as well as PGS for common liability for externalizing and general substance use disorders, were used to examine genetic associations with the exposome factors. After adjusting for participant sex, age, log income-to-needs ratio, and genetic ancestry principal components, higher PGS for psychiatric (e.g., broad externalizing liability, attention deficit hyperactivity disorder) and substance use disorders (e.g., general substance use disorders, cannabis use disorder) were positively associated with household adversity and negatively associated with positive day-to-day experiences. Our results indicate that polygenic risk for psychiatric and substance use disorders correlate with environmental factors in adolescence at multiple levels, most notably household adversity and positive day-to-day experiences. Findings underscore the importance of investigating rGE when examining these environmental exposures with genetic risk for psychiatric and substance use disorders.
Indexed as
Identifiers
42886211What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.